GlassScriptPhysician profile
Larry C Stutts
NPI 1063488922
$2,896.23
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $83.52 · 2021: $1,107 · 2022: $1,138 · 2023: $207 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.92 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,125.34 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $1,000.00 | 2022 | |
| Roche Diagnostics Corporation | $152.80 | 2019-2021 | |
| Astellas Pharma US INC | $130.19 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $82.05 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $81.51 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $76.41 | 2021-2023 | |
| Intuitive Surgical, INC. | $66.80 | 2022 | |
| Amgen INC. | $54.88 | 2019-2023 | Prolia, Evenity |
| Myovant Sciences INC. | $30.00 | 2021 | |
| Exeltis, USA INC. | $29.09 | 2020 | |
| Acell, INC. | $23.21 | 2019 | |
| Minerva Surgical, INC | $16.65 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.39 | 2019 | |
| Radius Health, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Stutts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.